Area of research
Hematology · Genetics
Research interest
Research interests include Cancer research, Medicine, Oncology, Myelodysplastic syndromes, GiST, and Myeloid leukemia.
Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia
MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients
Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST)
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
Circulating <i>cKIT</i> and <i>PDGFRA</i> DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST)
Inhibition of PLK1 by capped‐dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells